Firma VITROCELL Systems, Autor bei Presse-Blog

VITROCELL® 12/12 now available with Climatic Chamber

2. Dezember 202018. Juli 2023 Firma VITROCELL SystemsMedizintechnikaerosol exposure, air-liquid Interface, airborne substances, cell culture inserts, cell cultures, climatic chamber, complex mixtures, docking station, fibers, gases, humidification, lung cells, nanoparticles, toxicity testing, VITROCELL

The VITROCELL® 12/12 module system has been designed to facilitate the exposure of mammalian cell cultures to airborne substances such as gases, complex mixtures, nanoparticles and fibers. It features a throughput of 3 dilution steps @ 3 replicates and 1 clean Mehr

New Video: VITROCELL® Cloud α – for Aerosol Research and Cell Exposure at the Air/Liquid Interface (ALI)

20. Oktober 202018. Juli 2023 Firma VITROCELL SystemsBiotechnikaerosol generator, air-liquid Interface, airborne particles, cell cultures, inhalation exposure, inhaled drugs, inhaled substances, liquid aerosol, mammalian cells, microbalance, nanoparticles, screening, toxicity testing, virus research, VITROCELL Cloud

The VITROCELL® Cloud Alpha series is our newest innovation and presents a great leap forward in automated exposure of cell cultures. It combines reliable exposure of cell cultures from the respiratory tract with ease of use. This series is our Mehr

VITROCELL® Shisha Testing System for Cell Cultures

21. September 202018. Juli 2023 Firma VITROCELL SystemsMedizintechnikair-liquid Interface, cell cultures, chemical analysis, exposure, inhalation, ISO 22486, lung cells, nicotine, shisha, smoking machine, testing, tobacco, water pipe, waterpipe

. Background Emissions of water pipe tobacco can now be tested by in vitro exposure in a reliable and user-friendly setup. The novel Shisha Testing Device can be combined with any VITROCELL® Exposure System. The same setup can also be Mehr

VITROCELL® Cloud Alpha 96

24. August 202018. Juli 2023 Firma VITROCELL SystemsBiotechnikaerosol generator, air-liquid Interface, airborne particles, inhalation exposure, inhaled drugs, inhaled substances, liquid aerosol, mammalian cells, microbalance, nanoparticles, screening, toxicity testing, VITROCELL Cloud

The VITROCELL® Cloud Alpha 96 is our newest innovation and presents a great leap forward in automated exposure of cell cultures. It combines high throughput testing with ease of use. The development is based on the well-known and frequently published Mehr

VITROCELL® holder systems for e-cigarettes

27. Juli 202018. Juli 2023 Firma VITROCELL SystemsMedizintechnikcom-patible with Alto, compatible with GLO, compatible with IQOS, compatible with JUUL, compatible with Logic, compatible with myblu, compatible with tank products, compatible with vype, e-cigarettes, holder systems, smoking machines, VITROCELL

New designs of electronic cigarettes such as ENDS (Electronic Nicotine Delivery Systems) products or HTP (Heated Tobacco Products) lead to a large variety of different shapes which make the insertion into conventional holders with labyrinth seals impossible. VITROCELL® has developed a Mehr

VITROCELL® TEM Grid holders for dose determination of airborne particles during in vitro Exposure at the air / liquid interface

25. Juni 2020 Firma VITROCELL SystemsForschung und Entwicklungair liquid, airborne particles, biological research, disease research, dose determination, Exposure systems, in vitro, in vitro Exposure, inhalation toxicology, kit, lung cells, nano particles, TEM Grid, Transmission Electron Microscopy, VITROCELL

. Background The assessment of toxicological effects of airborne particles to the human organism is of major importance in disease research. The presence of nano and ultrafine particles can be found both in indoor and outdoor atmospheres which include workplaces Mehr

Screening antiviraler pharmazeutischer Leitwirkstoffe gegen das Coronavirus (COVID-19 / SARS-CoV-2)

31. März 202018. Juli 2023 Firma VITROCELL SystemsMedizintechnikaerosol, cloud, covid-19, in vitro, Leitwirkstoffe, Lungenzellen, medikamente, modell, Sars CoV 2, screening, system, virus, virusforschung, zellkulturmodell

In der Inhalationstherapie werden pharmazeutische Präparate als Aerosole auf Zellen des Atemtraktes im Nasen- oder Lungenbereich appliziert. Zur präklinischen Entwicklung neuer Arzneimittel werden dafür oft kommerziell erhältliche, physiologisch relevante in vitro Zellkulturmodelle des Nasen-, Rachen- oder Lungenepithels verwendet. In jüngster Mehr

Screening of antiviral lead compounds against coronavirus (COVID-19; SARS-CoV-2)

31. März 202018. Juli 2023 Firma VITROCELL SystemsMedizintechnikair-blood barrier, cell culture model, cloud, covid-19, drug development, in vitro, infections, model, nasal region, pulmonary epithelium, Sars CoV 2, screening, system, therapy

In inhalation therapy, drugs are deposited as aerosols on cells of the respiratory tract from the nasal or lung region. For preclinical drug development, physiologically realistic in vitro cell culture models of the pulmonary epithelium and the air-blood barrier as Mehr

Autor: Firma VITROCELL Systems